PLGA-PEI nanoparticle covered with poly(I:C) for personalised cancer immunotherapy
Drug Delivery and Translational Research · 2024-10 · 14 (10) · 2788-2803
DOI: 10.1007/s13346-024-01557-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Delivery and Translational Research, online erschienen am 01.03.2024. Verfasst von Lorena Gonzalez-Melero und 7 weiteren Autor:innen. Beteiligte Einrichtung: NanoBioCel Research Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, Spain. Hauptthemen laut MEDLINE: Poly I-C, Nanoparticles, Immunotherapy, Cancer Vaccines. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad del País Vasco.
Abstract (Originalsprache)
Melanoma is the main cause of death among skin cancers and its incidence worldwide has been experiencing an appalling increase. However, traditional treatments lack effectiveness in advanced or metastatic patients. Immunotherapy, meanwhile, has been shown to be an effective treatment option, but the rate of cancers responding remains far from ideal. Here we have developed a personalized neoantigen peptide-based cancer vaccine by encapsulating patient derived melanoma neoantigens in polyethylenimine (PEI)-functionalised poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) and coating them with polyinosinic:polycytidylic acid (poly(I:C)). We found that PLGA NPs can be effectively modified to be coated with the immunoadjuvant poly(I:C), as well as to encapsulate neoantigens. In addition, we found that both dendritic cells (DCs) and lymphocytes were effectively stimulated. Moreover, the developed NP was found to have a better immune activation profile than NP without poly(I:C) or without antigen. Our results demonstrate that the developed vaccine has a high capacity to activate the immune system, efficiently maturing DCs to present the antigen of choice and promoting the activity of lymphocytes to exert their cytotoxic function. Therefore, the immune response generated is optimal and specific for the elimination of melanoma tumour cells. Graphical abstract Created with BioRender.com
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NanoBioCel Research Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, Spain.
- Bioaraba, NanoBioCel Research Group, Vitoria-Gasteiz, Spain.
- Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Institute of Health Carlos III, Madrid, Spain.
- Department of Biochemistry and Molecular Biology, School of Pharmacy, University of Santiago de Compostela, Santiago, Spain.
- Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela, Santiago, Spain.
- Health Research Institute of Santiago de Compostela (IDIS), Santiago, Spain.
ORCID-Profile: Lorena Gonzalez-Melero, Edorta Santos-Vizcaino, Ruben Varela-Calvino, Iria Gomez-Tourino, Aintzane Asumendi, Maria Dolores Boyano, Manoli Igartua, Rosa Maria Hernandez
Förderung
- Universidad del País Vasco
Zitieren
APA
Gonzalez-Melero, L., Santos-Vizcaino, E., Varela-Calvino, R., Gomez-Tourino, I., Asumendi, A., Boyano, M. D., Igartua, M., & Hernandez, R. M. (2024). PLGA-PEI nanoparticle covered with poly(I:C) for personalised cancer immunotherapy. Drug Delivery and Translational Research, 14(10), 2788-2803. https://doi.org/10.1007/s13346-024-01557-2
Vancouver
Gonzalez-Melero L, Santos-Vizcaino E, Varela-Calvino R, Gomez-Tourino I, Asumendi A, Boyano MD, et al. PLGA-PEI nanoparticle covered with poly(I:C) for personalised cancer immunotherapy. Drug Delivery and Translational Research. 2024;14(10):2788-2803. doi:10.1007/s13346-024-01557-2
BibTeX
@article{GonzalezMelero2024,
author = {Gonzalez-Melero, Lorena and Santos-Vizcaino, Edorta and Varela-Calvino, Ruben and Gomez-Tourino, Iria and Asumendi, Aintzane and Boyano, Maria Dolores and Igartua, Manoli and Hernandez, Rosa Maria},
title = {PLGA-PEI nanoparticle covered with poly(I:C) for personalised cancer immunotherapy},
journal = {Drug Delivery and Translational Research},
year = {2024},
volume = {14},
number = {10},
pages = {2788--2803},
doi = {10.1007/s13346-024-01557-2}
}
EUVIMED